Vivo Capital, LLC Valneva Se Transaction History

Vivo Capital, LLC

  • $677 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$27.1 - $67.28 $5.42 Million - $13.5 Million
-200,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$25.02 - $53.38 $5 Million - $10.7 Million
-200,000 Reduced 50.0%
200,000 $6.28 Million
Q2 2021

Aug 16, 2021
BUY
$24.41 - $31.04 $9.76 Million - $12.4 Million
400,000 New
400,000 $10.5 Million

Others Institutions Holding VALN

# of Institutions
13
Shares Held
683K
Call Options Held
0
Put Options Held
0
View Full List

About Valneva SE

VALN Quotes by TradingView
  • Ticker VALN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,103,504
  • Market Cap $386M
  • Description
  • Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...
More about VALN
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email